eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity

Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications, Diabet. Med., 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Huang, 2009, eNOS, metabolic syndrome and cardiovascular disease, Trends Endocrinol. Metab., 20, 295, 10.1016/j.tem.2009.03.005 Huang, 2009, A comprehensive definition for metabolic syndrome, Dis. Models Mech., 2, 231, 10.1242/dmm.001180 Hink, 2001, Mechanisms underlying endothelial dysfunction in diabetes mellitus, Circ. Res., 88, E14, 10.1161/01.RES.88.2.e14 Gimbrone, 2000, Endothelial dysfunction, hemodynamic forces, and atherogenesis, Ann. NY Acad. Sci., 902, 230, 10.1111/j.1749-6632.2000.tb06318.x discussion 239–40. Gimbrone, 1989, Endothelial dysfunction and atherosclerosis, J. Card. Surg., 4, 180, 10.1111/j.1540-8191.1989.tb00275.x Dudzinski, 2006, The regulation and pharmacology of endothelial nitric oxide synthase, Annu. Rev. Pharmacol. Toxicol., 46, 235, 10.1146/annurev.pharmtox.44.101802.121844 Huang, 1995, Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature, 377, 239, 10.1038/377239a0 Freedman, 1999, Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene, Circ. Res., 84, 1416, 10.1161/01.RES.84.12.1416 Kuhlencordt, 2001, Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice, Circulation, 104, 448, 10.1161/hc2901.091399 Lefer, 1999, Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice, Am. J. Physiol., 276, H1943 Moroi, 1998, Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice, J. Clin. Invest., 101, 1225, 10.1172/JCI1293 Murohara, 1998, Nitric oxide synthase modulates angiogenesis in response to tissue ischemia, J. Clin. Invest., 101, 2567, 10.1172/JCI1560 Huang, 2005, Unraveling the links between diabetes, obesity, and cardiovascular disease, Circ. Res., 96, 1129, 10.1161/01.RES.0000170705.56583.45 Wang, 1995, Nitric oxide synthases: gene structure and regulation, Adv. Pharmacol., 34, 71, 10.1016/S1054-3589(08)61081-9 Bode-Boger, 1996, Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits, Biochem. Biophys. Res. Commun., 219, 598, 10.1006/bbrc.1996.0279 Cooke, 2000, Does ADMA cause endothelial dysfunction?, Arterioscler .Thromb. Vasc. Biol., 20, 2032, 10.1161/01.ATV.20.9.2032 Cosentino, 1998, Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats, J. Clin. Invest., 101, 1530, 10.1172/JCI650 Shaul, 2002, Regulation of endothelial nitric oxide synthase: location, location, location, Annu. Rev. Physiol., 64, 749, 10.1146/annurev.physiol.64.081501.155952 Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224 Fulton, 1999, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, 399, 597, 10.1038/21218 Chen, 1999, AMP-activated protein kinase phosphorylation of endothelial NO synthase, FEBS Lett., 443, 285, 10.1016/S0014-5793(98)01705-0 Hisamoto, 2001, Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells, J. Biol. Chem., 276, 3459, 10.1074/jbc.M005036200 Kureishi, 2000, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, Nat. Med., 6, 1004, 10.1038/79510 Montagnani, 2001, Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179), J. Biol. Chem., 276, 30392, 10.1074/jbc.M103702200 Scotland, 2002, Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion, Circ. Res., 90, 904, 10.1161/01.RES.0000016506.04193.96 Vecchione, 2002, Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway, Diabetes, 51, 168, 10.2337/diabetes.51.1.168 Chen, 2003, Adiponectin stimulates production of nitric oxide in vascular endothelial cells, J. Biol. Chem., 278, 45021, 10.1074/jbc.M307878200 Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J. Biol. Chem., 279, 1304, 10.1074/jbc.M310389200 Atochin, 2007, The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo, J. Clin. Invest., 117, 1961, 10.1172/JCI29877 Kahn, 2000, Obesity and insulin resistance, J. Clin. Invest., 106, 473, 10.1172/JCI10842 Balon, 1997, Evidence that nitric oxide increases glucose transport in skeletal muscle, J. Appl. Physiol., 82, 359, 10.1152/jappl.1997.82.1.359 Higaki, 2001, Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle, Diabetes, 50, 241, 10.2337/diabetes.50.2.241 McGrowder, 2006, Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds, J. Biosci., 31, 347, 10.1007/BF02704107 Roy, 1998, Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent, Am. J. Physiol., 274, E692 Tanaka, 2003, Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes, Eur. J. Endocrinol., 149, 61, 10.1530/eje.0.1490061 Petrie, 1996, Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease, Circulation, 93, 1331, 10.1161/01.CIR.93.7.1331 Steinberg, 1994, Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release, J. Clin. Invest., 94, 1172, 10.1172/JCI117433 Steinberg, 1996, Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance, J. Clin. Invest., 97, 2601, 10.1172/JCI118709 Nisoli, 2004, Mitochondrial biogenesis as a cellular signaling framework, Biochem. Pharmacol., 67, 1, 10.1016/j.bcp.2003.10.015 Nisoli, 2003, Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide, Science, 299, 896, 10.1126/science.1079368 Duplain, 2001, Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase, Circulation, 104, 342, 10.1161/01.CIR.104.3.342 Shankar, 2000, Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance, Diabetes, 49, 684, 10.2337/diabetes.49.5.684 Cook, 2004, Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension, Diabetes, 53, 2067, 10.2337/diabetes.53.8.2067 Cook, 2003, Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice, Swiss Med. Wkly., 133, 360 Schleicher, 2009, The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo, Sci. Signal., 2, ra41, 10.1126/scisignal.2000343